Return to search results.
Complete title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Study of ARN-509 in Men with Non-Metastatic (M0) Castration-Resistant Prostate Cancer
|Research Study Number||20130328|
|Principal Investigator||Tia Higano, MD|
Research Study Description
Eligibility Criteria (must meet the following to participate in this study)
Other eligibility criteria may apply.
Genitourinary Cancer; Prostate Cancer; Solid Tumors
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.